Endoplasmic reticulum as a therapeutic target in type 2 diabetes: Role of phytochemicals

Soraya Sajadimajd1, Niloofar Deravi2, Kimia Forouhar3

  • 1Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.

Insights

Medicinal plants offer promising alternatives for managing type 2 diabetes mellitus (T2DM). Phytochemicals alleviate endoplasmic reticulum (ER) stress, a key factor in T2DM progression and complications.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • Type 2 diabetes mellitus (T2DM) is a global health issue marked by insulin resistance and beta-cell dysfunction.
  • Chronic glucotoxicity induces endoplasmic reticulum (ER) stress, leading to beta-cell failure and disease progression.
  • Existing antidiabetic drugs have limited long-term efficacy, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To comprehensively review the role of phytochemicals in alleviating ER stress in T2DM.
  • To explore the potential of herbal constituents as therapeutic agents for T2DM and its complications.

Main Methods:

  • Literature review of studies investigating phytochemicals and their effects on ER stress in T2DM.
  • Analysis of data on specific phytochemicals and their impact on T2DM-related pathways.
  • Compilation of evidence for the efficacy of herbal compounds in managing T2DM complications.

Main Results:

  • Ginsenoside compound K, baicalein, quercetin, and others improve T2DM by modulating ER stress.
  • Arctigenin and peony glycosides show efficacy in diabetic retinopathy via ER stress modulation.
  • Grape seed proanthocyanidins, wolfberry, and resveratrol demonstrate benefits for diabetic neuropathy, retinopathy, and atherosclerosis by targeting ER stress.

Conclusions:

  • Herbal constituents possess the capability to prevent T2DM complications by reducing ER stress.
  • Phytochemicals targeting ER stress represent a promising avenue for novel diabetes treatments.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
328
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
383
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K